India, Nov. 21 -- India's clinical research landscape has undergone a remarkable evolution. From modest beginnings in the early 1990s to becoming a globally recognised destination for trials, the sector has matured significantly in terms of science, ethics, and regulatory oversight. Regulations have become more robust, with stronger emphasis on patient safety and quality assurance.

Globally, the clinical research market was valued at $80.74 billion in 2023 and is projected to reach $123.54 billion by 2030. Closer home, the Indian CRO market is set to nearly double from $0.73 billion in 2024 to $1.32 billion by 2032, reflecting India's growing role in the global healthcare ecosystem. This growth underscores the crucial role CROs play in h...